Bonnie Henry
Bonnie Henry
Provincial Health Oficer
Province of British Columbia
Dr. Bonnie Henry was appointed as provincial health officer (PHO) for the Province of BC on February 1, 2018. Prior to her appointment as PHO, Bonnie had already served as the deputy provincial health officer for three years and had served as the interim provincial executive medical director of the BC Centre for Disease Control from December 2013 until August 2014.

Bonnie was also the medical director of Communicable Disease Prevention and Control and Public Health Emergency Management with the British Columbia Centre for Disease Control and medical director for the provincial emerging and vector-borne diseases program as well as a provincial program for surveillance and control of healthcare associated infections; a position she started in February of 2005.

In 2003, Bonnie was the operational lead in the response to the SARS outbreak in Toronto. And has worked internationally including with the WHO/UNICEF polio eradication program in Pakistan and with the World Health Organization to control the Ebola outbreak in Uganda.

Bonnie is a specialist in public health and preventive medicine and is board certified in preventive medicine in the U.S. She graduated from Dalhousie Medical School and completed a Masters in Public Health in San Diego, residency training in preventive medicine at University of California, San Diego and in community medicine at University of Toronto.

Mel Krajden
Mel Krajden
Medical Director
BC Centre for Disease Control
Dr. Mel Krajden is a professor of Pathology and Laboratory Medicine at the University of British Columbia in Vancouver, British Columbia, Canada. Mel obtained his BSc, MD, and FRCPC (Internal Medicine) at McGill University followed by a fellowship in Infectious Diseases at Stanford University. He is also the Medical Director of the Public Health Laboratory at the British Columbia Centre for Disease Control.

Mel serves on Health Canada's Expert Advisory Committee on Blood Regulation and Expert Advisory Committee on Cells, Tissues, and Organs. His role on these is because of his expertise in medical microbiology, immunology, internal medicine and infectious diseases. Mel is also the Treasurer of the Association of Medical Microbiology and Infectious Disease Canada.

In addition to numerous publications in peer-reviewed journals, Mel has been quoted in the lay press on subjects such as human metapneumovirus, SARS and COVID-19.

Carl Hansen
Carl Hansen
CEO
AbCellera Biologics Inc.
Dr. Carl Hansen is the founder and CEO of AbCellera Biologics Inc. Until August 2019, Carl was a Professor at the University of British Columbia, where he co-authored over 65 manuscripts in the fields of microfluidics, immunology, genomics, and nanotechnology. He is an inventor of over 50 US patents and 63 US patent applications that are represented in 7 commercial products. He received the Michael Smith Career investigator award and was recently named one of the “Top 5 Canadian CEOs who elevate their companies.”

Carl received his PhD in Applied Physics / Biotechnology from Caltech, and a BASc in Engineering Physics and Honors Mathematics from the University of British Columbia. Before leading AbCellera, he was a scientific Co-Founder of Precision Nanosystems, a Vancouver-based company developing next-generation delivery technology for genetic medicines, and served on the SAB of Fluidigm Corp.